Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality
- 5 July 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 27 (8), 1321-1323
- https://doi.org/10.1038/s41591-021-01440-4
Abstract
No abstract availableKeywords
Funding Information
- Research Grants Council, University Grants Committee (SRFS2021-7S03)
This publication has 8 references indexed in Scilit:
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccinationNature Reviews Immunology, 2021
- BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humansPublished by Cold Spring Harbor Laboratory ,2020
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKThe Lancet, 2020
- An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine, 2020
- WHO position on the use of fractional doses – June 2017, addendum to vaccines and vaccination against yellow fever WHO: Position paper – June 2013Vaccine, 2017
- Human papillomavirus vaccines: WHO position paper, May 2017–RecommendationsVaccine, 2017
- Fractional dosing of yellow fever vaccine to extend supply: a modelling studyThe Lancet, 2016